Driven by Innovation & Growth

Our mission is to promote innovation and growth through strengthened networks; advocacy; capital investment; talent attraction, development and retention; and advancing the next generation of leaders.

About Us

Virginia's Life Science Community By the Numbers

  • 1,451 Companies

    Life science companies in Virginia.

  • $8B Industry

    Life Science contributes $8B to Virginia's economy.

  • 26,545 People

    Employed by Life Science companies in Virginia.

  • $77,848 Average Wage

    Average earnings of life science workers in Virginia.

  • 1,197 Clinical trials

    Biopharmaceutical industry-sponsored trials in Virginia per year.

News

10/02/2024

Afton Scientific to Expand Biopharmaceutical Facility in Albemarle County

Governor Glenn Youngkin announced that Afton Scientific, a manufacturer of sterile injectable pharmaceuticals, will invest over $200 million to expand its biopharmaceutical manufacturing facility in Albemarle County. The project will create hundreds of new jobs. Virginia successfully competed with several states for the project. “Afton Scientific’s multi-million dollar expansion in Albemarle County is a powerful testament

10/01/2024

Governor Glenn Youngkin Announces Over $2.5 Million in Growth and Opportunity Virginia Grants

Governor Glenn Youngkin today announced more than $2.5 million in Growth and Opportunity for Virginia (GO Virginia) grant awards for 21 projects focused on creating workforce pipelines for targeted industries and supporting the cultivation of critical industry resources to attract and grow Virginia-based businesses. “GO Virginia enables us to make strategic investments in pivotal projects

09/30/2024

AgroSpheres Secures $37M Series B Funding – Pushes for Growth

AgroSpheres Inc. (AGS), a biotechnology leader in sustainable crop protection and crop health, today announced the final close of a $37 million Series B funding round led by Zebra Impact Ventures, which invests through the Regenerative Growth I strategy, run in partnership with Mirabaud Asset Management. The round also saw strong participation from existing investors